Protocol Summary
Protocol No.
167840 (10553)
Principal Investigator
Kerrigan, Kathleen
Phase
II
Age Group
Adult
ClinicalTrials.Gov
NCT05669664 (Click to jump to clinicaltrials.gov)
Contact
Sophie Campbell
u1253452@utah.edu
Title
Phase II Study of Darolutamide in Combination with Leuprolide Acetate in Hormone-Therapy Naïve Recurrent and/or Metastatic Androgen Receptor (AR) Positive Salivary Gland Cancer
Objective
Applicable Disease Sites
Head/Neck
Participating Institutions
Huntsman Cancer Institute : Sophie Campbell
Status
Open
Clinical trials search powered by Forte Research Systems
